New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls. Read the Q3 2026 report

AstraZeneca PLC

AZN

Healthcare Drug Manufacturers General

AstraZeneca PLC’s revenue for fiscal 2025 (year ended December 2025) was $58.7 billion, up 8.63% from fiscal 2024.

Revenue
+6.70%
EPS
+23.5%
Free cash flow
+1.99%
Total debt
+1.75%

Quarter to September 2026, against a year earlier

175.60 0.15 +0.09%
Market cap
$272.1B
P/E
24.6×
Fwd P/E FY26e
24.2×
Dividend yield
1.83%
F-score
9/9
ROIC
12.3%
Net debt / EBITDA
1.1×
Payout ratio
0.5×

What it owns vs. what it owes End of fiscal 2025, Dec 31, 2025

It owes $22.0B more in debt than it holds in cash and short-term investments. Debt has risen from $16.8B to $27.8B since FY16. Shareholders’ equity is 42.7% of the balance sheet. What is a balance sheet?

Dec 31, 2025 · total $114.1B

Owns

$85.4BLong-term assets
$22.9BOther short-term assets
$5.8BCash & short-term investments

Funded by

$48.7BShareholders’ equity
$37.5BOther liabilities
$27.8BDebt

Debt is 24.4% of the total; shareholders’ equity 42.7%.

Net debt has held near 19% of assets since FY16.

Total assetsNet debt (debt less cash)Net debt ÷ assets (right axis)
Assets and net debt, ten years
FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25
Total assets$62.5B$63.4B$60.7B$61.4B$66.7B$105.4B$96.5B$101.1B$104.0B$114.1B
Net debt (debt less cash)$10.9B$13.2B$13.2B$11.3B$11.6B$23.3B$21.8B$21.4B$23.1B$22.0B
Net debt ÷ assets (right axis)17.4%20.9%21.7%18.4%17.3%22.1%22.6%21.2%22.2%19.3%
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Total current assets
28,723.00 25,827.00 25,054.00 22,593.00 26,244.00 19,544.00 15,563.00 15,591.00 13,150.00 13,262.00
Total non-current assets
85,351.00 78,208.00 76,065.00 73,890.00 79,119.00 47,185.00 45,814.00 45,060.00 50,204.00 49,264.00
Total Assets
114,074.00 104,035.00 101,119.00 96,483.00 105,363.00 66,729.00 61,377.00 60,651.00 63,354.00 62,526.00
Total current liabilities
30,617.00 27,866.00 30,542.00 26,293.00 22,594.00 20,307.00 18,117.00 16,292.00 16,383.00 15,256.00
Total non-current liabilities
34,738.00 35,298.00 31,411.00 33,132.00 43,482.00 30,784.00 28,664.00 30,315.00 30,329.00 30,601.00
Total liabilities
65,355.00 63,164.00 61,953.00 59,425.00 66,076.00 51,091.00 46,781.00 46,607.00 46,712.00 45,857.00
Common Equity (Total)
48,719.00 40,871.00 39,166.00 37,058.00 39,287.00 15,638.00 14,596.00 14,044.00 16,642.00 16,669.00
Shareholders Equity (Total)
48,719.00 40,871.00 39,166.00 37,058.00 39,287.00 15,638.00 14,596.00 14,044.00 16,642.00 16,669.00
Total Debt
27,819.00 28,843.00 27,494.00 28,279.00 29,794.00 19,699.00 17,552.00 19,113.00 17,807.00 16,808.00

Show all line items

In millions of $ except per-share values · columns are period end dates · fundamentals updated Nov 18, 2026